Načítá se...

(18)F-Fluorodeoxyglucose positron-emission tomography could have a prognostic role in patients with advanced hepatocellular carcinoma

INTRODUCTION: We set out to evaluate the prognostic value of (18)F-fluorodeoxyglucose positron-emission tomography (pet) in patients with advanced (non-transplant-eligible) hepatocellular carcinoma (hcc) and to evaluate the correlation between standardized uptake values (suvs) and survival outcomes....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Simoneau, E., Hassanain, M., Madkhali, A., Salman, A., Nudo, C.G., Chaudhury, P., Metrakos, P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117622/
https://ncbi.nlm.nih.gov/pubmed/25089106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.21.1959
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!